277 related articles for article (PubMed ID: 12077276)
1. Complement deficiency ameliorates collagen-induced arthritis in mice.
Hietala MA; Jonsson IM; Tarkowski A; Kleinau S; Pekna M
J Immunol; 2002 Jul; 169(1):454-9. PubMed ID: 12077276
[TBL] [Abstract][Full Text] [Related]
2. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis.
Hietala MA; Nandakumar KS; Persson L; Fahlén S; Holmdahl R; Pekna M
Eur J Immunol; 2004 Apr; 34(4):1208-16. PubMed ID: 15048732
[TBL] [Abstract][Full Text] [Related]
3. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis.
Wang Y; Kristan J; Hao L; Lenkoski CS; Shen Y; Matis LA
J Immunol; 2000 Apr; 164(8):4340-7. PubMed ID: 10754334
[TBL] [Abstract][Full Text] [Related]
4. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
[TBL] [Abstract][Full Text] [Related]
5. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
Banda NK; Thurman JM; Kraus D; Wood A; Carroll MC; Arend WP; Holers VM
J Immunol; 2006 Aug; 177(3):1904-12. PubMed ID: 16849503
[TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
7. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.
Bäcklund J; Nandakumar KS; Bockermann R; Mori L; Holmdahl R
J Immunol; 2003 Oct; 171(7):3493-9. PubMed ID: 14500645
[TBL] [Abstract][Full Text] [Related]
8. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
9. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
Song H; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2007 Dec; 179(11):7860-7. PubMed ID: 18025232
[TBL] [Abstract][Full Text] [Related]
10. Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice.
Zhang HG; Yang P; Xie J; Liu Z; Liu D; Xiu L; Zhou T; Wang Y; Hsu HC; Mountz JD
J Immunol; 2002 Apr; 168(8):4164-72. PubMed ID: 11937577
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.
Iwai H; Kozono Y; Hirose S; Akiba H; Yagita H; Okumura K; Kohsaka H; Miyasaka N; Azuma M
J Immunol; 2002 Oct; 169(8):4332-9. PubMed ID: 12370365
[TBL] [Abstract][Full Text] [Related]
12. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
Banda NK; Kraus DM; Muggli M; Bendele A; Holers VM; Arend WP
J Immunol; 2003 Aug; 171(4):2109-15. PubMed ID: 12902517
[TBL] [Abstract][Full Text] [Related]
13. Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis.
Kagari T; Tanaka D; Doi H; Shimozato T
J Immunol; 2003 Apr; 170(8):4318-24. PubMed ID: 12682268
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
Banda NK; Vondracek A; Kraus D; Dinarello CA; Kim SH; Bendele A; Senaldi G; Arend WP
J Immunol; 2003 Feb; 170(4):2100-5. PubMed ID: 12574381
[TBL] [Abstract][Full Text] [Related]
15. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
16. The mouse model of collagen-induced arthritis.
Brand DD; Kang AH; Rosloniec EF
Methods Mol Med; 2004; 102():295-312. PubMed ID: 15286392
[TBL] [Abstract][Full Text] [Related]
17. IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints.
Chu CQ; Song Z; Mayton L; Wu B; Wooley PH
Ann Rheum Dis; 2003 Oct; 62(10):983-90. PubMed ID: 12972478
[TBL] [Abstract][Full Text] [Related]
18. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.
Svendsen P; Andersen CB; Willcox N; Coyle AJ; Holmdahl R; Kamradt T; Fugger L
J Immunol; 2004 Dec; 173(11):7037-45. PubMed ID: 15557201
[TBL] [Abstract][Full Text] [Related]
19. Germinal center reaction in the joints of mice with collagen-induced arthritis: an animal model of lymphocyte activation and differentiation in arthritis joints.
Han S; Cao S; Bheekha-Escura R; Zheng B
Arthritis Rheum; 2001 Jun; 44(6):1438-43. PubMed ID: 11407706
[TBL] [Abstract][Full Text] [Related]
20. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.
Chiba A; Tajima R; Tomi C; Miyazaki Y; Yamamura T; Miyake S
Arthritis Rheum; 2012 Jan; 64(1):153-61. PubMed ID: 21904999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
